WWSG Exclusive
Former CEO, Aster Insights; Operating Advisor, Clayton, Dubilier & Rice; Adjunct Professor of Health Policy and Medical Ethics, University of Pennsylvania; Deputy Commissioner for Medical and Scientific Affairs, Food and Drug Administration (2020-2021); Senior Medical Advisor, Centers for Medicare & Medicaid Services (2019-2020); Chief Medical Officer, Center for Medicare & Medicaid Innovation (2017-2019); Oncologist
Anand Shah, M.D. offers event planners a speaker who has truly shaped the healthcare system from the inside—leading at the FDA and CMS while also building and advising companies at the cutting edge of life sciences. He delivers a compelling, behind-the-scenes view of how medical innovation moves from idea to impact, and what leaders must do to succeed in today’s highly regulated, fast-changing environment. With the credibility of a physician and the perspective of a CEO, Dr. Shah engages audiences with insights that are timely, practical, and immediately relevant.
Anand Shah Talks About the Unknowns of AI in Healthcare
The View from Washington | CNBC Healthy Returns Summit
Closing the Chasm Between FDA, Payors, & Patients | HLTH
Differences Between Healthcare Agencies | Medtech Venture & Partnering Conference
Leadership | Medtech Venture & Partnering Conference
Digital Health | Medtech Venture & Partnering Conference
The integration of artificial intelligence, especially generative AI, is revolutionizing medicine, promising to transform everything from diagnostics and drug discovery to patient experience and hospital operations. Dr. Shah offers a unique perspective on this critical turning point, grounded in hands-on operational experience as a CEO and investor, deep medical and clinical expertise, and an understanding of the intricate policy and regulatory challenges that govern deployment. He shares a pragmatic blueprint for how health systems and life sciences companies can accelerate their current technologies to scalable, safe, and value-generating tools. Dr. Shah discusses the political and regulatory pressure points, analyzing how policymakers must balance fostering innovation with ensuring AI products are safe, effective, and free from algorithmic bias, ultimately providing leaders with a roadmap for strategically investing in and governing technology that improves patient care and operational efficiency.
For Fortune 500 boards, health and well-being are increasingly material enterprise risks demanding full board oversight, impacting talent retention, operational resilience, and the core duty of care. Dr. Shah reframes this duty by outlining the critical intersection of health policy, digital transformation, and corporate liability, sharing insights from his experience as a board director and CEO. He equips directors to oversee three strategic domains: workforce health & human capital (covering burnout, mental health parity, and the massive financial exposure of employee benefits plans); cybersecurity & data governance (focusing on the increased targeting of executive and patient health data, and regulatory compliance under rapidly evolving state and federal standards); and community & customer health outcomes (discussing the impact of shifting public health trends and market-access policy on core business operations). This presentation is a mandate for boards to move beyond reactive compliance and integrate health strategy into core business planning to protect both shareholder value and human capital.
The rise of longevity and lifestyle medicine reflects a growing dissatisfaction among Americans with a fragmented traditional healthcare system focused on treating ailments rather than preventing them. As patients struggle to access high-quality primary care, they are increasingly turning toward a “do-it-yourself” healthcare ecosystem, driven by direct-to-consumer services, wearables, and social media. Dr. Shah leverages his experience as both an oncologist and a pioneer in the health optimization clinic model to unpack this seismic shift. He analyzes the risks and rewards of the DIY movement and emerging business models. He explores the pitfalls of pitting traditional American medicine against longevity and lifestyle approaches, offering instead a framework for integrating these philosophies as essential, complementary components of a future-proof healthcare system.
As a leading health care expert and oncologist caring for the elderly, Dr. Shah shares his experiences navigating and shaping primary and specialty care in America. He focuses his presentation on potential solutions to the problems Medicare beneficiaries encounter related to a fragmented health care system. Dr. Shah discusses in depth the critical political, economic, and data challenges in implementing meaningful health care reform. He discusses the impact of value-based care on the realignment of incentives for patients, providers, and payers.
Unprecedented advances in biomedical innovation such as precision medicine, cell and gene therapies, regenerative medicine, and artificial intelligence require new regulatory and health care delivery paradigms to sustain affordable access for patients and consumers. Dr. Shah discusses the latest trends and opportunities along the arc of innovation that spans from discovery and investment to delivery and payment. How do we bridge the valley that often stands between new medical products and their delivery to the patient’s bedside? What are new potential frameworks for health care that can ensure continued innovation, improve the quality of care, and decrease costs?
The Covid pandemic served as a stark and costly global test of leadership, exposing critical vulnerabilities in public and private sector preparedness and collaboration. Drawing on his experience working closely with industry, academia, and government leaders—including spearheading the development of the FDA’s COVID-19 Pandemic Recovery and Preparedness Plan—Dr. Shah moves beyond the rearview mirror to prepare leaders for the next era of emerging threats. He contextualizes the lessons learned from infectious disease outbreaks like Ebola, Mpox, and Zika, alongside growing crises such as antimicrobial resistance (AMR) and the devastating opioid and fentanyl crisis. Dr. Shah discusses the importance of an integrated approach to early recognition and action, securing global supply chains, operations, crisis communications and policy. He educates leaders on developing agile, structured frameworks for distilling lessons learned in real-time, enabling organizations to inform future strategic planning and build the resilience required to withstand the next unpredictable public health challenge.
Anand Shah, M.D. is a business leader with extensive experience as a CEO, physician, and in the senior-most levels of government. He is focused on the development and application of technologies to improve human health. With a unique background at the nexus of life sciences and health care delivery, Dr. Shah has advanced new medical innovations to the marketplace, expanded patient and consumer access, and improved health outcomes for Americans.
He was previously an operating advisor at global investment firm CD&R where he developed and identified investment opportunities. During his tenure with CD&R, Dr. Shah successfully guided CD&R portfolio company Aster Insights as CEO through its strategic sale. He was a senior advisor and executive-in-residence at Morgan Stanley. Throughout his career, Dr. Shah has served on numerous public, private, and nonprofit boards.
In the U.S. government, he held successive leadership roles including as the Deputy Commissioner for Medical and Scientific Affairs at the U.S. Food and Drug Administration (FDA), Senior Medical Advisor at the Centers for Medicare & Medicaid Services (CMS), and the Chief Medical Officer of the Center for Medicare & Medicaid Innovation (CMMI) at CMS.
Dr. Shah is a radiation oncologist with a substantial scientific track record, including the New England Journal of Medicine, JAMA, and Health Affairs. At the National Institutes of Health (NIH), he led a survivorship clinic for patients on clinical trials. He is currently on faculty at the University of Pennsylvania and serves as a major in the Maryland Defense Force as its medical director.
Dr. Shah was chief resident during his radiation oncology residency at Columbia University. He concurrently earned his M.D. from the University of Pennsylvania and an M.P.H. in health care management and policy from the Harvard School of Public Health. Dr. Shah graduated with honors from Duke University with a degree in economics. He was a Canada-U.S. Fulbright Scholar.
All timing and logistics were seamless, and the client was super engaged and thankful. I’m happy to report that we have another WIN for WWSG! Let’s build on the momentum together!
Josh Linkner, Tech Entrepreneur, Hyper-Growth CEO, NYT Best-Selling Author, Venture Capitalist, and Keynote Speaker
The team at WWSG is certainly at the top of the scale. Building a long-term relationship with the client has really set WWSG apart and we clearly saw that with our partnership. WWSG found creative ways to build the partnership which results in a win-win for all.
Erik Qualman, Top Technology and Motivational Speaker, #1 Bestselling Author & Futurist
The consistent professionalism and quality for the way Worldwide Speakers Group handles events shows that they think of each detail and every contingency beforehand.
Newt Gingrich, Distinguished Leader, Visionary, & Political Vanguard; 2012 Republican Presidential Candidate; Speaker of the U.S. House of Representatives (1995-1999); Best-Selling Author
After 20 years in the lecture series business, WWSG has become a valued partner. We produce over 24 speaking events a year and have worked with dozens of agencies. We appreciate WWSG’s unparalleled professionalism, integrity, and creativity in suggesting speakers that are unique to the speaker circuit.
The Distinguished Speaker Series of Southern California
Thanks again for all your help. Your entire team there is truly stellar.
American Property Casualty Insurance Association
They provide us well-prepared and informed speakers who understand our expectations and unique format. With WWSG, we know that the speaker fees are fair and trust that the event will be a success.
The Distinguished Speaker Series of Southern California
Everything was buttoned up, from the initial outreach to the event execution and post follow-up. I have a great team of representatives from WWSG to work with, first class experience.
American Century Investments
The WWSG team are super responsive and flexible. I will definitely work with them again to find speakers for my next event.
Ernst & Young LLP
I hope to work again and again with Worldwide Speakers Group on the selection of our keynote and endnote speakers for our annual conference and other events. Our representative and her associate were terrific from my first communication to them until our speaking-event concluded... It is easy to see why many of the top speakers in the country work with Worldwide Speakers Group.
The National Recreation and Park Association
We always enjoy working with WWSG, and we thank you and your team for your diligence, thoroughness, and professionalism. Planning is already underway for next year's event (no rest for the weary). We hope to have every opportunity to work with you again in the near future.
Texas American Resources Company
Thank you to our WWSG agent and event coordinator for their partnership in the planning and execution of this session. You are all incredible professionals to work with and represent your elite speakers so well. The entire experience could not have been better.
Financial Horizons
